NO regulates PDGF-induced activation of PKB but not ERK in A7r5 cells: Implications for vascular growth arrest

American Journal of Physiology - Cell Physiology

Volumn 279, Issue 1 48-1, 2000, Pages

  Sandirasegarane, Lakshman ^a   Charles, Roger ^a   Bourbon, Nicole ^a   Kester, Mark ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Extracellular signal regulated kinase; Growth factors; Nitric oxide; Platelet derived growth factor; Proliferation; Protein kinase B; Vascular smooth muscle cell

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 8 BROMO CYCLIC GMP; CYCLIC GMP; ENDOTHELIN 1; GROWTH FACTOR; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE B;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GROWTH REGULATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0033855477     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.2000.279.1.c225     Document Type: Article

References (40)

1. Nerve growth factor promotes activation of the α, β and γ isoforms of protein kinase B in PC12 pheochromocytoma cells
2. Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype
3. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation
4. Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation
5. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP
6. Sphingolipid metabolites differentially regulate extracellular signal- regulated kinase and stress-activated protein kinase cascades
7. A redox-triggered Ras-effector interaction. Recruitment of phosphatidylinositol 3'-kinase to Ras by redox stress
8. Dual effect of nitric oxide donors on cyclooxygenase-2 expression in human mesangial cells
9. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells. Involvement in suppression of apoptosis
10. Activation of nitric oxide synthase in endothelial cells by Akt- dependent phosphorylation
11. Inhibition of neointimal smooth muscle cell accumulation after angioplasty by an antibody to PDGF
12. Growth factors and mitogen-activated protein kinases
13. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
14. Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle
15. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
16. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one
17. Platelet-derived growth factor stimulates protein kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells
18. Nitric oxide inhibits proliferation of human endothelial cells via a mechanism independent of cGMP
19. Akt signaling: Linking membrane events to life and death decisions
20. Induction of the cyclin-dependent kinase inhibitor p21(Sdi1/ Cip1/Waf1) by nitric Oxide-generating vasodilator in vascular smooth muscle cells
21. Sphingolipids as mediators of effects of platelet-derived growth factor in vascular smooth muscle cells
22. Endothelin-1 and angiotensin II act as progression but not competence growth factors in vascular smooth muscle cells
23. Low increases in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes
24. Molecular cloning and characterization of a new member of the RAC protein kinase family: Association of the pleckstrin homology domain of three types of RAC protein kinase with protein kinase C subspecies and βγ subunits of G proteins
25. Molecular cloning of rat RAC protein kinase α and β and their association with protein kinase Cζ
26. Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt
27. Inhibitory effects of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives on vascular smooth muscle cell mitogenesis and proliferation in vitro
28. A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction
29. Nitric oxide inhibits Fas-induced apoptosis
30. Mevalonate deprivation impairs IGF-I/ insulin signaling in human vascular smooth muscle cells
31. cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase
32. The pathogenesis of atherosclerosis: A perspective for the 1990s
33. The nitric oxide donors, SNAP and DEA/NO, exert a negative inotropic effect in rat cardiomyocytes which is independent of cyclic GMP elevation
34. FK409, a new nitric oxide donor, suppresses smooth muscle proliferation in the rat model of balloon angioplasty
35. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide
36. Nitric oxide fully protects against UVA-induced apoptosis in tight correlation with Bcl-2 upregulation
37. Gene therapy inhibiting neointimal hyperplasia: In vivo transfer of endothelial nitric oxide synthase gene
38. Platelet-derived growth factor-BB and thrombin activate phosphoinositide 3-kinase and protein kinase B: Role in mediating airway smooth muscle proliferation
39. Endothelin-1 potentiates human smooth muscle cell growth to PDGF. Effects of ETA and ET(B) receptor blockade
40. cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway